Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
118775762 | 11877576 | 2 | F | 19980921 | 20160826 | 20151230 | 20160826 | EXP | FR-BRISTOL-MYERS SQUIBB COMPANY-10171460 | BRISTOL MYERS SQUIBB | 14.00 | DY | F | Y | 3.60000 | KG | 20160826 | CN | FR | FR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
118775762 | 11877576 | 1 | PS | ZERIT | STAVUDINE | 1 | Unknown | UNK | U | 20413 | ORAL SOLUTION | ||||||||
118775762 | 11877576 | 2 | SS | ZERIT | STAVUDINE | 1 | Transplacental | UNK | U | 0 | CAPSULE, HARD | ||||||||
118775762 | 11877576 | 3 | SS | EPIVIR | LAMIVUDINE | 1 | Transplacental | UNK | U | 0 | |||||||||
118775762 | 11877576 | 4 | SS | INVIRASE | SAQUINAVIR MESYLATE | 1 | Transplacental | UNK | U | 0 | |||||||||
118775762 | 11877576 | 5 | C | BACTRIM | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Transplacental | UNK | U | 0 | |||||||||
118775762 | 11877576 | 6 | C | PENTACARINAT | PENTAMIDINE ISETHIONATE | 1 | Transplacental | 300 MG, UNK | U | 0 | 300 | MG | |||||||
118775762 | 11877576 | 7 | C | AUGMENTIN | AMOXICILLINCLAVULANATE POTASSIUM | 1 | Transplacental | UNK | U | 0 | |||||||||
118775762 | 11877576 | 8 | C | VITAMIN B + MAGNESIUM | 2 | Transplacental | UNK | U | 0 | ||||||||||
118775762 | 11877576 | 9 | C | CHLORQUINALDOL + PROMESTRIENE | 2 | Transplacental | UNK | U | 0 | ||||||||||
118775762 | 11877576 | 10 | C | DAKTARIN | MICONAZOLE NITRATE | 1 | Transplacental | UNK | U | 0 | |||||||||
118775762 | 11877576 | 11 | C | POLYGYNAX | 2 | Transplacental | UNK | U | 0 | ||||||||||
118775762 | 11877576 | 12 | C | ERCEFURYL | NIFUROXAZIDE | 1 | Transplacental | 100 MG, UNK | U | 0 | 100 | MG |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
118775762 | 11877576 | 1 | Product used for unknown indication |
118775762 | 11877576 | 2 | Product used for unknown indication |
118775762 | 11877576 | 3 | Product used for unknown indication |
118775762 | 11877576 | 4 | Product used for unknown indication |
118775762 | 11877576 | 5 | Product used for unknown indication |
118775762 | 11877576 | 6 | Product used for unknown indication |
118775762 | 11877576 | 7 | Product used for unknown indication |
118775762 | 11877576 | 8 | Product used for unknown indication |
118775762 | 11877576 | 9 | Product used for unknown indication |
118775762 | 11877576 | 10 | Product used for unknown indication |
118775762 | 11877576 | 11 | Product used for unknown indication |
118775762 | 11877576 | 12 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
118775762 | 11877576 | HO |
118775762 | 11877576 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
118775762 | 11877576 | Agitation | |
118775762 | 11877576 | Anaemia | |
118775762 | 11877576 | Blood lactic acid increased | |
118775762 | 11877576 | Dystonia | |
118775762 | 11877576 | Foetal exposure during pregnancy | |
118775762 | 11877576 | Gastrooesophageal reflux disease | |
118775762 | 11877576 | Muscle contractions involuntary | |
118775762 | 11877576 | Tongue coated |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |